Abstract

SummaryThe SARS-CoV-2 spike protein is a critical component of vaccines and a target for neutralizing monoclonal antibodies (nAbs). Spike is also undergoing immunogenic selection with variants that increase infectivity and partially escape convalescent plasma. Here, we describe Spike Display, a high-throughput platform to rapidly characterize glycosylated spike ectodomains across multiple coronavirus-family proteins. We assayed ∼200 variant SARS-CoV-2 spikes for their expression, ACE2 binding, and recognition by 13 nAbs. An alanine scan of all five N-terminal domain (NTD) loops highlights a public epitope in the N1, N3, and N5 loops recognized by most NTD-binding nAbs. NTD mutations in variants of concern B.1.1.7 (alpha), B.1.351 (beta), B.1.1.28 (gamma), B.1.427/B.1.429 (epsilon), and B.1.617.2 (delta) impact spike expression and escape most NTD-targeting nAbs. Finally, B.1.351 and B.1.1.28 completely escape a potent ACE2 mimic. We anticipate that Spike Display will accelerate antigen design, deep scanning mutagenesis, and antibody epitope mapping for SARS-CoV-2 and other emerging viral threats.

Highlights

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic, causing > 200 million infections and > 4.3 million deaths worldwide

  • SARS-CoV-2 spike interacts with angiotensin-converting enzyme 2 (ACE2) and other cell surface receptors to mediate fusion between the virus envelope and cell membrane (Cantuti-Castelvetri et al, 2020; Yan et al, 2020; Zhang et al, 2020)

  • The S1 subunit, which is composed of the N-terminal domain (NTD) and receptor-binding domain (RBD) (Wrapp et al, 2020), is the key determinant of tissue and host tropism (Li, 2016)

Read more

Summary

Introduction

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic, causing > 200 million infections and > 4.3 million deaths worldwide (as of August 14, 2021). SARS-CoV-2 spike interacts with angiotensin-converting enzyme 2 (ACE2) and other cell surface receptors to mediate fusion between the virus envelope and cell membrane (Cantuti-Castelvetri et al, 2020; Yan et al, 2020; Zhang et al, 2020). The S1 subunit, which is composed of the N-terminal domain (NTD) and receptor-binding domain (RBD) (Wrapp et al, 2020), is the key determinant of tissue and host tropism (Li, 2016)

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.